Management of the parotid for high-risk cutaneous squamous cell carcinoma: A review from the salivary section of the American Head and Neck Society

Am J Otolaryngol. 2022 Mar-Apr;43(2):103374. doi: 10.1016/j.amjoto.2022.103374. Epub 2022 Feb 2.

Abstract

Background: Metastases to the parotid nodal basin in patients with high-risk cutaneous squamous cell carcinoma (HRcSCC) impact disease specific survival (DSS) and overall survival (OS).

Methods: A writing group convened by the Salivary Section of the American Head and Neck Society (AHNS) developed contemporary, evidence-based recommendations regarding management of the parotid nodal basin in HRcSCC based on available literature, expert consultation, and collective experience. The statements and recommendations were then submitted and approved by the AHNS Salivary Committee.

Results: These recommendations were developed given the wide variation of practitioners who treat HRcSCC in order to streamline management of the parotid nodal basin including indications for imaging, surgery, radiation, and systemic treatment options as well.

Conclusions: This clinical update represents contemporary optimal management of the parotid nodal basin in HRcSCC and is endorsed by the Salivary Section of the AHNS.

Keywords: Cutaneous squamous cell carcinoma; Elective parotidectomy; High risk cutaneous squamous cell carcinoma; Parotid metastases; Parotid nodal basin.

Publication types

  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms* / pathology
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Lymph Nodes / pathology
  • Neoplasm Staging
  • Parotid Gland / surgery
  • Parotid Neoplasms* / pathology
  • Parotid Neoplasms* / therapy
  • Retrospective Studies
  • Skin Neoplasms* / pathology
  • United States